Denver, United States
Pluto Bio offers a transformative platform for drug discovery teams, epitomized by its slogan: "Translational science infrastructure for drug discovery teams." Unlike typical platforms that merely provide data, Pluto Bio empowers translational teams to articulate scientific queries within a comprehensive framework, fostering alignment on scientific objectives.
The platform allows delegating multi-omics data analysis to either in-house scientists or Pluto Bio's agents, enhancing precision in data interpretation. This approach generates verifiable evidence addressing pivotal program criteria. Additionally, users can create publication-ready visuals and comprehensive reports, streamlining program benchmarking across portfolios.
Founded in 2020 and headquartered in the United States, Pluto Bio operates within sectors spanning Analytics, Life Sciences, SaaS, and Machine Learning. In a recent Seed Round on 02 May 2023, they secured a $3.70M investment from Silverton Partners, showcasing investor confidence in their innovative capabilities.
